Wang et al. confirmed that CD147 was not only an MMP stimulator but also a proangiogenic molecule, and anti-CD147mAb showed stronger antiangiogenic effects than infliximab, thereby suppressing RA development [42]. Here, BSG is linked to rheumatoid arthritis.